Nykode Therapeutics ASA (NYKD) — Working Capital to Net Assets Ratio
Nykode Therapeutics ASA (NYKD) has a Working Capital to Net Assets ratio of 58.2% as of March 2026. Working capital of Nkr50.95 Million (current assets of Nkr55.31 Million minus current liabilities of Nkr4.37 Million) is measured against net assets of Nkr87.51 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Nykode Therapeutics ASA assets under control.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Nykode Therapeutics ASA Working Capital to Net Assets (2016–2025)
This chart shows how Nykode Therapeutics ASA's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 58.2%, reflecting working capital of Nkr50.95 Million against net assets of Nkr87.51 Million NOK. Explore NYKD capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Nykode Therapeutics ASA (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Nykode Therapeutics ASA from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Nykode Therapeutics ASA (NYKD) financial obligations for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 60.8% | Nkr55.70 Million | Nkr91.54 Million | Nkr61.89 Million | Nkr6.19 Million | ▼ -18.4 pp |
| 2024 | 79.3% | Nkr107.97 Million | Nkr136.21 Million | Nkr117.07 Million | Nkr9.10 Million | ▼ -5.4 pp |
| 2023 | 84.7% | Nkr145.07 Million | Nkr171.26 Million | Nkr165.68 Million | Nkr20.61 Million | ▼ -25.4 pp |
| 2022 | 110.1% | Nkr172.89 Million | Nkr157.02 Million | Nkr211.87 Million | Nkr38.98 Million | ▼ -5.6 pp |
| 2021 | 115.7% | Nkr224.49 Million | Nkr194.06 Million | Nkr255.86 Million | Nkr31.37 Million | ▼ -5.0 pp |
| 2020 | 120.7% | Nkr215.85 Million | Nkr178.85 Million | Nkr229.03 Million | Nkr13.18 Million | ▲ +16.3 pp |
| 2019 | 104.4% | Nkr253.32 Million | Nkr242.56 Million | Nkr291.22 Million | Nkr37.91 Million | ▲ +4.8 pp |
| 2018 | 99.7% | Nkr139.59 Million | Nkr140.07 Million | Nkr152.85 Million | Nkr13.27 Million | ▼ -0.1 pp |
| 2017 | 99.8% | Nkr203.09 Million | Nkr203.53 Million | Nkr214.03 Million | Nkr10.94 Million | ▼ 0.0 pp |
| 2016 | 99.8% | Nkr23.15 Million | Nkr23.19 Million | Nkr24.89 Million | Nkr1.74 Million | — |